Disability Discrimination by Clinical Algorithm

61 Pages Posted: 29 Jul 2023 Last revised: 15 Jan 2025

See all articles by Elizabeth Pendo

Elizabeth Pendo

University of Washington - School of Law

Jennifer D. Oliva

Indiana University Maurer School of Law; Georgetown University Law Center; UCSF/UC Law Consortium on Law, Science & Health Policy

Date Written: July 27, 2023

Abstract

In response to America’s escalating drug poisoning crisis, the federal government has funded, incentivized, and mandated that states adopt and implement prescription drug monitoring programs (PDMPs) to electronically surveil controlled substances and other “drugs of concern.” State PDMPs utilize proprietary, predictive software platforms that deploy algorithms to determine whether a patient is at risk for drug misuse, drug diversion, doctor shopping, or substance use disorder. PDMPs have never been validated by a federal agency or peer review, yet states have mandated their use throughout the health care delivery system.

Research demonstrates that clinical overreliance on the risk scores generated by PDMP algorithms motivates clinicians to refuse to treat—or to inappropriately treat—marginalized and stigmatized patient populations, including individuals with actual or perceived substance use disorder, chronic pain conditions, or other disabilities. The misuse of information generated by PDMP algorithms by health care providers is anticipated to impact over 1 billion patient encounters each year. This article provides a framework for challenging such PDMP algorithmic discrimination as disability discrimination. It contends that Section 504 of the Rehabilitation Act, the Americans with Disabilities Act, and Section 1557 of the Accountable Care Act can be engaged to protect vulnerable patients from PDMP-related algorithmic discrimination and provides recommendations to develop and strengthen the 2024 Section 1557 final rule concerned with clinical-decision algorithmic discrimination, harmonize new and existing antidiscrimination protections, and improve implementation and enforcement efforts in this context.

Keywords: Rehabilitation Act, Americans with Disabilities Act, Section 1557 of the Affordable Care Act, disability discrimination, drug poisoning crisis, health equity, substance use disorder, opioid use disorder, disparate treatment, disparate impact, refusal to prescribe, refusal to treat, abandonment,

Suggested Citation

Pendo, Elizabeth and Oliva, Jennifer, Disability Discrimination by Clinical Algorithm (July 27, 2023). 103 North Carolina Law Review 187 (2024), Indiana Legal Studies Research Paper No. 540, Available at SSRN: https://ssrn.com/abstract=4523314 or http://dx.doi.org/10.2139/ssrn.4523314

Elizabeth Pendo

University of Washington - School of Law ( email )

William H. Gates Hall
Box 353020
Seattle, WA 98105-3020
United States

Jennifer Oliva (Contact Author)

Indiana University Maurer School of Law ( email )

211 S. Indiana Avenue
Bloomington, IN 47405
United States

HOME PAGE: http://law.indiana.edu/about/people/details/oliva-jennifer-d.html

Georgetown University Law Center ( email )

600 New Jersey Avenue NW
Washington, DC 20001
United States

HOME PAGE: http://oneill.law.georgetown.edu/experts/jennifer-oliva/

UCSF/UC Law Consortium on Law, Science & Health Policy ( email )

200 McAllister Street
San Francisco, CA 94102
United States

HOME PAGE: http://www.uchastings.edu/people/jennifer-d-oliva/

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Downloads
305
Abstract Views
1,046
Rank
214,695
PlumX Metrics